NCT04542876View on ClinicalTrials.gov

Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection

NACompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

May 1, 2020

Primary Completion Date

July 31, 2020

Study Completion Date

August 18, 2020

Conditions
Covid19
Interventions
DRUG

Guduchi Ghan Vati

Guduchi Ghan Vati was orally administered 2 tablets (1000 mg) twice daily for 2 weeks.

Trial Locations (1)

Unknown

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University, Jodhpur

All Listed Sponsors
collaborator

Dr. Sarvepalli Radhakrishnan Rajasthan Ayurved University

OTHER

lead

Aarogyam UK

OTHER

NCT04542876 - Efficacy and Safety of Guduchi Ghan Vati in the Management of Asymptomatic COVID-19 Infection | Biotech Hunter | Biotech Hunter